SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3lgg'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_A_DCFA353_1
(ADENOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		8 / 12 HIS A  86
HIS A  88
ASP A  89
HIS A 330
GLU A 333
HIS A 358
ASP A 415
ASP A 416
 ZN  A 512 (-3.4A)
CFE  A 513 ( 3.3A)
CFE  A 513 (-3.0A)
ZN  A 512 ( 3.5A)
CFE  A 513 (-3.0A)
CFE  A 513 ( 4.3A)
CFE  A 513 ( 2.8A)
CFE  A 513 (-2.8A)
 0.86A 1a4lA-3lggA:
33.7		 1a4lA-3lggA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_A_DCFA353_1
(ADENOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		6 / 12 HIS A  86
HIS A  88
PHE A 181
HIS A 330
ASP A 415
ASP A 416
 ZN  A 512 (-3.4A)
CFE  A 513 ( 3.3A)
CFE  A 513 (-4.8A)
ZN  A 512 ( 3.5A)
CFE  A 513 ( 2.8A)
CFE  A 513 (-2.8A)
 1.22A 1a4lA-3lggA:
33.7		 1a4lA-3lggA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_A_DCFA353_1
(ADENOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		9 / 12 HIS A  86
HIS A  88
PHE A 181
PHE A 185
HIS A 330
GLU A 333
HIS A 358
ASP A 415
ASP A 416
 ZN  A 512 (-3.4A)
CFE  A 513 ( 3.3A)
CFE  A 513 (-4.8A)
CFE  A 513 ( 3.7A)
ZN  A 512 ( 3.5A)
CFE  A 513 (-3.0A)
CFE  A 513 ( 4.3A)
CFE  A 513 ( 2.8A)
CFE  A 513 (-2.8A)
 0.60A 1a4lA-3lggA:
33.7		 1a4lA-3lggA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_A_DCFA353_1
(ADENOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		6 / 12 HIS A  86
PHE A 420
PHE A 181
HIS A 358
ASP A 415
ASP A 416
 ZN  A 512 (-3.4A)
None
CFE  A 513 (-4.8A)
CFE  A 513 ( 4.3A)
CFE  A 513 ( 2.8A)
CFE  A 513 (-2.8A)
 1.31A 1a4lA-3lggA:
33.7		 1a4lA-3lggA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_B_DCFB853_1
(ADENOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		7 / 12 HIS A  88
ASP A  89
HIS A 330
GLU A 333
HIS A 358
ASP A 415
ASP A 416
 CFE  A 513 ( 3.3A)
CFE  A 513 (-3.0A)
ZN  A 512 ( 3.5A)
CFE  A 513 (-3.0A)
CFE  A 513 ( 4.3A)
CFE  A 513 ( 2.8A)
CFE  A 513 (-2.8A)
 0.95A 1a4lB-3lggA:
33.9		 1a4lB-3lggA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_B_DCFB853_1
(ADENOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		5 / 12 HIS A  88
LEU A 389
PHE A 181
HIS A 330
ASP A 416
 CFE  A 513 ( 3.3A)
None
CFE  A 513 (-4.8A)
ZN  A 512 ( 3.5A)
CFE  A 513 (-2.8A)
 1.31A 1a4lB-3lggA:
33.9		 1a4lB-3lggA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_B_DCFB853_1
(ADENOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		7 / 12 HIS A  88
PHE A 181
PHE A 185
HIS A 330
HIS A 358
ASP A 415
ASP A 416
 CFE  A 513 ( 3.3A)
CFE  A 513 (-4.8A)
CFE  A 513 ( 3.7A)
ZN  A 512 ( 3.5A)
CFE  A 513 ( 4.3A)
CFE  A 513 ( 2.8A)
CFE  A 513 (-2.8A)
 0.67A 1a4lB-3lggA:
33.9		 1a4lB-3lggA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_B_DCFB853_1
(ADENOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		7 / 12 HIS A  88
PHE A 185
HIS A 330
GLU A 333
HIS A 358
ASP A 415
ASP A 416
 CFE  A 513 ( 3.3A)
CFE  A 513 ( 3.7A)
ZN  A 512 ( 3.5A)
CFE  A 513 (-3.0A)
CFE  A 513 ( 4.3A)
CFE  A 513 ( 2.8A)
CFE  A 513 (-2.8A)
 0.45A 1a4lB-3lggA:
33.9		 1a4lB-3lggA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_C_DCFC1353_1
(ADENOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		8 / 12 HIS A  86
HIS A  88
ASP A  89
HIS A 330
GLU A 333
HIS A 358
ASP A 415
ASP A 416
 ZN  A 512 (-3.4A)
CFE  A 513 ( 3.3A)
CFE  A 513 (-3.0A)
ZN  A 512 ( 3.5A)
CFE  A 513 (-3.0A)
CFE  A 513 ( 4.3A)
CFE  A 513 ( 2.8A)
CFE  A 513 (-2.8A)
 0.82A 1a4lC-3lggA:
33.7		 1a4lC-3lggA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_C_DCFC1353_1
(ADENOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		6 / 12 HIS A  86
HIS A  88
PHE A 181
HIS A 330
ASP A 415
ASP A 416
 ZN  A 512 (-3.4A)
CFE  A 513 ( 3.3A)
CFE  A 513 (-4.8A)
ZN  A 512 ( 3.5A)
CFE  A 513 ( 2.8A)
CFE  A 513 (-2.8A)
 1.17A 1a4lC-3lggA:
33.7		 1a4lC-3lggA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_C_DCFC1353_1
(ADENOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		9 / 12 HIS A  86
HIS A  88
PHE A 181
PHE A 185
HIS A 330
GLU A 333
HIS A 358
ASP A 415
ASP A 416
 ZN  A 512 (-3.4A)
CFE  A 513 ( 3.3A)
CFE  A 513 (-4.8A)
CFE  A 513 ( 3.7A)
ZN  A 512 ( 3.5A)
CFE  A 513 (-3.0A)
CFE  A 513 ( 4.3A)
CFE  A 513 ( 2.8A)
CFE  A 513 (-2.8A)
 0.59A 1a4lC-3lggA:
33.7		 1a4lC-3lggA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_C_DCFC1353_1
(ADENOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		6 / 12 HIS A  86
PHE A 420
PHE A 181
HIS A 358
ASP A 415
ASP A 416
 ZN  A 512 (-3.4A)
None
CFE  A 513 (-4.8A)
CFE  A 513 ( 4.3A)
CFE  A 513 ( 2.8A)
CFE  A 513 (-2.8A)
 1.28A 1a4lC-3lggA:
33.7		 1a4lC-3lggA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_D_DCFD1853_1
(ADENOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		8 / 12 HIS A  88
ASP A  89
GLY A 300
HIS A 330
GLU A 333
HIS A 358
ASP A 415
ASP A 416
 CFE  A 513 ( 3.3A)
CFE  A 513 (-3.0A)
CFE  A 513 (-3.3A)
ZN  A 512 ( 3.5A)
CFE  A 513 (-3.0A)
CFE  A 513 ( 4.3A)
CFE  A 513 ( 2.8A)
CFE  A 513 (-2.8A)
 0.98A 1a4lD-3lggA:
33.5		 1a4lD-3lggA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_D_DCFD1853_1
(ADENOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		5 / 12 HIS A  88
PHE A 181
GLY A 300
HIS A 330
ASP A 416
 CFE  A 513 ( 3.3A)
CFE  A 513 (-4.8A)
CFE  A 513 (-3.3A)
ZN  A 512 ( 3.5A)
CFE  A 513 (-2.8A)
 1.35A 1a4lD-3lggA:
33.5		 1a4lD-3lggA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_D_DCFD1853_1
(ADENOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		8 / 12 HIS A  88
PHE A 181
PHE A 185
GLY A 300
HIS A 330
HIS A 358
ASP A 415
ASP A 416
 CFE  A 513 ( 3.3A)
CFE  A 513 (-4.8A)
CFE  A 513 ( 3.7A)
CFE  A 513 (-3.3A)
ZN  A 512 ( 3.5A)
CFE  A 513 ( 4.3A)
CFE  A 513 ( 2.8A)
CFE  A 513 (-2.8A)
 0.59A 1a4lD-3lggA:
33.5		 1a4lD-3lggA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_D_DCFD1853_1
(ADENOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		8 / 12 HIS A  88
PHE A 185
GLY A 300
HIS A 330
GLU A 333
HIS A 358
ASP A 415
ASP A 416
 CFE  A 513 ( 3.3A)
CFE  A 513 ( 3.7A)
CFE  A 513 (-3.3A)
ZN  A 512 ( 3.5A)
CFE  A 513 (-3.0A)
CFE  A 513 ( 4.3A)
CFE  A 513 ( 2.8A)
CFE  A 513 (-2.8A)
 0.41A 1a4lD-3lggA:
33.5		 1a4lD-3lggA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GX9_A_REAA1163_1
(BETA-LACTOGLOBULIN)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		5 / 11 LEU A 425
ILE A 260
GLU A 380
ILE A 219
PHE A 257
 None
 1.38A 1gx9A-3lggA:
undetectable		 1gx9A-3lggA:
16.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWJ_B_BAXB1723_2
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		3 / 3 ILE A 262
ASP A 297
PHE A 328
 None
 0.61A 1uwjB-3lggA:
undetectable		 1uwjB-3lggA:
19.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BXE_B_1FLB2001_1
(SERUM ALBUMIN)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		5 / 12 LEU A  87
ILE A 219
PHE A 257
GLY A 259
SER A 413
 None
 1.12A 2bxeB-3lggA:
undetectable		 2bxeB-3lggA:
20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IGT_C_SAMC1003_1
(SAM DEPENDENT
METHYLTRANSFERASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 4 ASP A 271
ASP A 310
ASP A 266
GLY A 305
 None
 1.30A 2igtC-3lggA:
undetectable		 2igtC-3lggA:
22.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OMB_A_IPHA2001_0
(BENCE JONES KWR
PROTEIN -
IMMUNOGLOBULIN LIGHT
CHAIN)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 5 HIS A 107
PRO A 106
TYR A 194
PRO A 196
 None
 1.29A 2ombA-3lggA:
undetectable
2ombB-3lggA:
undetectable		 2ombA-3lggA:
19.26
2ombB-3lggA:
19.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OMB_D_IPHD2002_0
(BENCE JONES KWR
PROTEIN -
IMMUNOGLOBULIN LIGHT
CHAIN)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 7 PRO A 196
HIS A 107
PRO A 106
TYR A 194
 None
 1.27A 2ombC-3lggA:
undetectable
2ombD-3lggA:
undetectable		 2ombC-3lggA:
19.26
2ombD-3lggA:
19.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OW9_A_HAEA502_1
(COLLAGENASE 3)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 6 LEU A 389
HIS A  86
HIS A  88
HIS A 330
 None
ZN  A 512 (-3.4A)
CFE  A 513 ( 3.3A)
ZN  A 512 ( 3.5A)
 0.91A 2ow9A-3lggA:
undetectable		 2ow9A-3lggA:
15.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PGF_A_ADNA501_1
(ADENOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		9 / 12 HIS A  88
ASP A  89
GLY A 300
HIS A 330
GLU A 333
HIS A 358
SER A 385
ASP A 415
ASP A 416
 CFE  A 513 ( 3.3A)
CFE  A 513 (-3.0A)
CFE  A 513 (-3.3A)
ZN  A 512 ( 3.5A)
CFE  A 513 (-3.0A)
CFE  A 513 ( 4.3A)
CFE  A 513 ( 4.5A)
CFE  A 513 ( 2.8A)
CFE  A 513 (-2.8A)
 0.64A 2pgfA-3lggA:
35.1		 2pgfA-3lggA:
25.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PGF_A_ADNA501_1
(ADENOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		9 / 12 HIS A  88
ASP A  89
PHE A 181
GLY A 300
HIS A 330
HIS A 358
SER A 385
ASP A 415
ASP A 416
 CFE  A 513 ( 3.3A)
CFE  A 513 (-3.0A)
CFE  A 513 (-4.8A)
CFE  A 513 (-3.3A)
ZN  A 512 ( 3.5A)
CFE  A 513 ( 4.3A)
CFE  A 513 ( 4.5A)
CFE  A 513 ( 2.8A)
CFE  A 513 (-2.8A)
 0.72A 2pgfA-3lggA:
35.1		 2pgfA-3lggA:
25.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PGR_A_DCFA501_1
(ADENOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		10 / 12 HIS A  86
HIS A  88
ASP A  89
PHE A 181
GLY A 300
HIS A 330
GLU A 333
HIS A 358
ASP A 415
ASP A 416
 ZN  A 512 (-3.4A)
CFE  A 513 ( 3.3A)
CFE  A 513 (-3.0A)
CFE  A 513 (-4.8A)
CFE  A 513 (-3.3A)
ZN  A 512 ( 3.5A)
CFE  A 513 (-3.0A)
CFE  A 513 ( 4.3A)
CFE  A 513 ( 2.8A)
CFE  A 513 (-2.8A)
 0.72A 2pgrA-3lggA:
35.0		 2pgrA-3lggA:
25.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 5 PHE A 289
PHE A 198
SER A 205
ILE A  92
 None
 1.30A 2v0mD-3lggA:
undetectable		 2v0mD-3lggA:
22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XAD_E_GCSE710_1
(N-ACYL GLM
PEUDO-TEICOPLANIN
DEACETYLASE
TEICOPLANIN)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 8 HIS A 330
ASP A 297
ILE A 263
HIS A  88
 ZN  A 512 ( 3.5A)
None
None
CFE  A 513 ( 3.3A)
 0.97A 2xadA-3lggA:
undetectable		 2xadA-3lggA:
19.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XAD_F_GCSF710_1
(N-ACYL GLM
PEUDO-TEICOPLANIN
DEACETYLASE
TEICOPLANIN)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 8 HIS A 330
ASP A 297
ILE A 263
HIS A  88
 ZN  A 512 ( 3.5A)
None
None
CFE  A 513 ( 3.3A)
 0.99A 2xadB-3lggA:
undetectable		 2xadB-3lggA:
19.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XAD_G_GCSG710_1
(N-ACYL GLM
PEUDO-TEICOPLANIN
DEACETYLASE
TEICOPLANIN)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 8 HIS A 330
ASP A 297
ILE A 263
HIS A  88
 ZN  A 512 ( 3.5A)
None
None
CFE  A 513 ( 3.3A)
 1.01A 2xadC-3lggA:
undetectable		 2xadC-3lggA:
19.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XAD_H_GCSH710_1
(N-ACYL GLM
PEUDO-TEICOPLANIN
DEACETYLASE
TEICOPLANIN)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 8 HIS A 330
ASP A 297
ILE A 263
HIS A  88
 ZN  A 512 ( 3.5A)
None
None
CFE  A 513 ( 3.3A)
 0.95A 2xadD-3lggA:
undetectable		 2xadD-3lggA:
19.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ABK_W_CHDW1059_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 1)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 5 ILE A 219
TYR A 201
ARG A 204
THR A  94
 None
 1.33A 3abkN-3lggA:
undetectable
3abkW-3lggA:
undetectable		 3abkN-3lggA:
21.16
3abkW-3lggA:
6.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BA0_A_HAEA477_1
(MACROPHAGE
METALLOELASTASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		3 / 3 HIS A  59
GLU A 168
HIS A 166
 None
 0.83A 3ba0A-3lggA:
undetectable		 3ba0A-3lggA:
20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BA0_A_HAEA477_1
(MACROPHAGE
METALLOELASTASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		3 / 3 HIS A 301
GLU A 182
HIS A 267
 None
CFE  A 513 (-3.0A)
CFE  A 513 (-3.9A)
 0.81A 3ba0A-3lggA:
undetectable		 3ba0A-3lggA:
20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3C0Z_A_SHHA301_1
(HISTONE DEACETYLASE
7A)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 5 HIS A  86
HIS A 330
ASP A 415
ASP A 416
 ZN  A 512 (-3.4A)
ZN  A 512 ( 3.5A)
CFE  A 513 ( 2.8A)
CFE  A 513 (-2.8A)
 1.17A 3c0zA-3lggA:
undetectable		 3c0zA-3lggA:
20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3C0Z_C_SHHC301_1
(HISTONE DEACETYLASE
7A)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 6 HIS A  86
HIS A 330
ASP A 415
ASP A 416
 ZN  A 512 (-3.4A)
ZN  A 512 ( 3.5A)
CFE  A 513 ( 2.8A)
CFE  A 513 (-2.8A)
 1.21A 3c0zC-3lggA:
undetectable		 3c0zC-3lggA:
20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IAZ_A_AINA1202_1
(LACTOTRANSFERRIN)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		3 / 3 GLU A 302
GLY A 305
THR A 304
 None
 0.56A 3iazA-3lggA:
undetectable		 3iazA-3lggA:
19.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KEC_A_HAEA272_1
(COLLAGENASE 3)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 5 LEU A 389
HIS A  86
HIS A  88
HIS A 330
 None
ZN  A 512 (-3.4A)
CFE  A 513 ( 3.3A)
ZN  A 512 ( 3.5A)
 0.98A 3kecA-3lggA:
undetectable		 3kecA-3lggA:
15.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LSK_B_ACTB901_0
(PYRANOSE 2-OXIDASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 6 SER A 385
PHE A 420
PHE A 185
HIS A  88
 CFE  A 513 ( 4.5A)
None
CFE  A 513 ( 3.7A)
CFE  A 513 ( 3.3A)
 1.40A 3lskB-3lggA:
undetectable		 3lskB-3lggA:
22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LSK_D_ACTD901_0
(PYRANOSE 2-OXIDASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 6 SER A 385
PHE A 420
PHE A 185
HIS A  88
 CFE  A 513 ( 4.5A)
None
CFE  A 513 ( 3.7A)
CFE  A 513 ( 3.3A)
 1.39A 3lskD-3lggA:
undetectable		 3lskD-3lggA:
22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N8X_A_NIMA701_2
(PROSTAGLANDIN G/H
SYNTHASE 1)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		3 / 3 VAL A 368
SER A 372
LEU A 362
 None
 0.77A 3n8xA-3lggA:
undetectable		 3n8xA-3lggA:
20.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NVC_A_SALA370_1
(GENTISATE
1,2-DIOXYGENASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 6 HIS A 358
HIS A 330
HIS A  86
ASP A 416
 CFE  A 513 ( 4.3A)
ZN  A 512 ( 3.5A)
ZN  A 512 (-3.4A)
CFE  A 513 (-2.8A)
 0.70A 3nvcA-3lggA:
undetectable		 3nvcA-3lggA:
20.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QPK_A_CUA602_0
(LACCASE-1)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		3 / 3 HIS A 330
HIS A  86
HIS A  88
 ZN  A 512 ( 3.5A)
ZN  A 512 (-3.4A)
CFE  A 513 ( 3.3A)
 0.54A 3qpkA-3lggA:
undetectable		 3qpkA-3lggA:
20.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QPK_B_CUB602_0
(LACCASE-1)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		3 / 3 HIS A 330
HIS A  86
HIS A  88
 ZN  A 512 ( 3.5A)
ZN  A 512 (-3.4A)
CFE  A 513 ( 3.3A)
 0.56A 3qpkB-3lggA:
undetectable		 3qpkB-3lggA:
20.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A7B_A_HAEA1273_1
(COLLAGENASE 3)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 6 LEU A 389
HIS A  86
HIS A  88
HIS A 330
 None
ZN  A 512 (-3.4A)
CFE  A 513 ( 3.3A)
ZN  A 512 ( 3.5A)
 0.91A 4a7bA-3lggA:
undetectable		 4a7bA-3lggA:
14.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4APJ_A_ACTA1635_0
(ANGIOTENSIN-CONVERTI
NG ENZYME
BRADYKININ-POTENTIAT
ING PEPTIDE B)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 6 HIS A 233
HIS A 234
GLU A 228
SER A 230
 None
 1.03A 4apjA-3lggA:
undetectable
4apjP-3lggA:
undetectable		 4apjA-3lggA:
21.90
4apjP-3lggA:
2.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AQL_A_TXCA1452_1
(GUANINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		6 / 12 HIS A 330
GLU A 333
GLU A 302
HIS A 358
SER A 385
ASP A 415
 ZN  A 512 ( 3.5A)
CFE  A 513 (-3.0A)
None
CFE  A 513 ( 4.3A)
CFE  A 513 ( 4.5A)
CFE  A 513 ( 2.8A)
 0.54A 4aqlA-3lggA:
2.4		 4aqlA-3lggA:
21.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BZ6_C_SHHC700_1
(HISTONE DEACETYLASE
8)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		5 / 12 GLY A 300
ASP A 416
HIS A  88
ASP A 415
HIS A  86
 CFE  A 513 (-3.3A)
CFE  A 513 (-2.8A)
CFE  A 513 ( 3.3A)
CFE  A 513 ( 2.8A)
ZN  A 512 (-3.4A)
 0.90A 4bz6C-3lggA:
undetectable		 4bz6C-3lggA:
20.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DR2_A_PARA1609_1
(16S RRNA
30S RIBOSOMAL
PROTEIN S9
30S RIBOSOMAL
PROTEIN S10)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		3 / 3 TYR A 264
ARG A 222
SER A 265
 None
 0.96A 4dr2I-3lggA:
undetectable
4dr2J-3lggA:
undetectable		 4dr2I-3lggA:
14.14
4dr2J-3lggA:
13.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1002_0
(BLUE COPPER OXIDASE
CUEO)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 4 HIS A  86
HIS A  88
HIS A 358
HIS A 330
 ZN  A 512 (-3.4A)
CFE  A 513 ( 3.3A)
CFE  A 513 ( 4.3A)
ZN  A 512 ( 3.5A)
 0.95A 4ef3A-3lggA:
undetectable		 4ef3A-3lggA:
20.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJ1_B_FOLB201_0
(DIHYDROFOLATE
REDUCTASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		5 / 12 ILE A 263
ALA A 221
LEU A 285
ILE A 279
LEU A 325
 None
 1.02A 4ej1B-3lggA:
undetectable		 4ej1B-3lggA:
16.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4I13_A_FOLA201_0
(DIHYDROFOLATE
REDUCTASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		5 / 12 ILE A 263
ALA A 221
LEU A 285
ILE A 279
LEU A 325
 None
 0.96A 4i13A-3lggA:
undetectable		 4i13A-3lggA:
16.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KHP_A_PARA1606_1
(16S RIBOSOMAL RNA
30S RIBOSOMAL
PROTEIN S9
30S RIBOSOMAL
PROTEIN S10)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		3 / 3 TYR A 264
ARG A 222
SER A 265
 None
 0.95A 4khpI-3lggA:
undetectable
4khpJ-3lggA:
undetectable		 4khpI-3lggA:
13.48
4khpJ-3lggA:
10.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LF7_A_PARA1817_1
(16S RRNA
RIBOSOMAL PROTEIN S9
RIBOSOMAL PROTEIN
S10)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		3 / 3 TYR A 264
ARG A 222
SER A 265
 None
 0.89A 4lf7I-3lggA:
undetectable
4lf7J-3lggA:
undetectable		 4lf7I-3lggA:
14.14
4lf7J-3lggA:
13.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LF8_A_PARA1817_1
(16S RRNA
RIBOSOMAL PROTEIN S9
RIBOSOMAL PROTEIN
S10)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		3 / 3 TYR A 264
ARG A 222
SER A 265
 None
 0.89A 4lf8I-3lggA:
undetectable
4lf8J-3lggA:
undetectable		 4lf8I-3lggA:
14.14
4lf8J-3lggA:
13.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R87_I_SPMI202_1
(SPERMIDINE
N1-ACETYLTRANSFERASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 7 ASN A  74
MET A  78
TYR A 430
GLU A  44
 None
 1.34A 4r87I-3lggA:
undetectable		 4r87I-3lggA:
18.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R88_A_1LDA501_0
(CYTOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		5 / 12 HIS A  88
HIS A 330
HIS A 358
LEU A 389
ASP A 415
 CFE  A 513 ( 3.3A)
ZN  A 512 ( 3.5A)
CFE  A 513 ( 4.3A)
None
CFE  A 513 ( 2.8A)
 0.27A 4r88A-3lggA:
21.0		 4r88A-3lggA:
22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R88_A_1LDA501_0
(CYTOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		5 / 12 HIS A  88
LEU A 389
HIS A 330
HIS A 358
ASP A 415
 CFE  A 513 ( 3.3A)
None
ZN  A 512 ( 3.5A)
CFE  A 513 ( 4.3A)
CFE  A 513 ( 2.8A)
 1.27A 4r88A-3lggA:
21.0		 4r88A-3lggA:
22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R88_B_1LDB501_0
(CYTOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		5 / 12 HIS A  88
HIS A 330
GLU A 333
LEU A 389
ASP A 415
 CFE  A 513 ( 3.3A)
ZN  A 512 ( 3.5A)
CFE  A 513 (-3.0A)
None
CFE  A 513 ( 2.8A)
 0.37A 4r88B-3lggA:
21.0		 4r88B-3lggA:
22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R88_C_1LDC501_0
(CYTOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		5 / 12 HIS A  88
HIS A 330
GLU A 333
LEU A 389
ASP A 415
 CFE  A 513 ( 3.3A)
ZN  A 512 ( 3.5A)
CFE  A 513 (-3.0A)
None
CFE  A 513 ( 2.8A)
 0.38A 4r88C-3lggA:
21.0		 4r88C-3lggA:
22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R88_D_1LDD501_0
(CYTOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		5 / 12 HIS A  88
HIS A 330
GLU A 333
LEU A 389
ASP A 415
 CFE  A 513 ( 3.3A)
ZN  A 512 ( 3.5A)
CFE  A 513 (-3.0A)
None
CFE  A 513 ( 2.8A)
 0.38A 4r88D-3lggA:
12.5		 4r88D-3lggA:
22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R88_E_1LDE501_0
(CYTOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		5 / 12 HIS A  88
HIS A 330
GLU A 333
LEU A 389
ASP A 415
 CFE  A 513 ( 3.3A)
ZN  A 512 ( 3.5A)
CFE  A 513 (-3.0A)
None
CFE  A 513 ( 2.8A)
 0.37A 4r88E-3lggA:
21.1		 4r88E-3lggA:
22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R88_F_1LDF502_0
(CYTOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		5 / 12 HIS A  88
HIS A 330
GLU A 333
LEU A 389
ASP A 415
 CFE  A 513 ( 3.3A)
ZN  A 512 ( 3.5A)
CFE  A 513 (-3.0A)
None
CFE  A 513 ( 2.8A)
 0.37A 4r88F-3lggA:
21.1		 4r88F-3lggA:
22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WQL_A_KANA203_1
(2''-AMINOGLYCOSIDE
NUCLEOTIDYLTRANSFERA
SE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		5 / 9 ASP A 416
ASP A 415
GLU A 380
ASP A 297
GLU A 302
 CFE  A 513 (-2.8A)
CFE  A 513 ( 2.8A)
None
None
None
 1.07A 4wqlA-3lggA:
0.0		 4wqlA-3lggA:
16.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XJE_A_TOYA202_1
(AADB)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 8 ASP A 416
ASP A 415
GLU A 380
ASP A 297
 CFE  A 513 (-2.8A)
CFE  A 513 ( 2.8A)
None
None
 1.04A 4xjeA-3lggA:
undetectable		 4xjeA-3lggA:
16.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CFS_A_TOYA203_1
(AAD(2''),GENTAMICIN
2''-NUCLEOTIDYLTRANS
FERASE,GENTAMICIN
RESISTANCE PROTEIN)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 8 ASP A 416
ASP A 415
GLU A 380
ASP A 297
 CFE  A 513 (-2.8A)
CFE  A 513 ( 2.8A)
None
None
 0.93A 5cfsA-3lggA:
undetectable		 5cfsA-3lggA:
16.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5H4D_A_BBIA403_1
(NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		4 / 6 PHE A  60
GLU A  68
PHE A  73
GLU A 208
 None
 1.03A 5h4dA-3lggA:
undetectable		 5h4dA-3lggA:
20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MIG_A_CUA601_0
(LACCASE 2)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		3 / 3 HIS A 330
HIS A  86
HIS A  88
 ZN  A 512 ( 3.5A)
ZN  A 512 (-3.4A)
CFE  A 513 ( 3.3A)
 0.49A 5migA-3lggA:
undetectable		 5migA-3lggA:
20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BXN_B_SAMB901_0
(DIPHTHAMIDE
BIOSYNTHESIS ENZYME
DPH2)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		5 / 12 GLY A 357
HIS A 330
VAL A 432
ILE A 412
ASP A 428
 None
ZN  A 512 ( 3.5A)
None
None
None
 1.34A 6bxnB-3lggA:
undetectable		 6bxnB-3lggA:
19.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6N91_A_DCFA401_0
(ADENOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		8 / 12 HIS A  88
ASP A  89
SER A 265
HIS A 330
GLU A 333
HIS A 358
ASP A 415
ASP A 416
 CFE  A 513 ( 3.3A)
CFE  A 513 (-3.0A)
None
ZN  A 512 ( 3.5A)
CFE  A 513 (-3.0A)
CFE  A 513 ( 4.3A)
CFE  A 513 ( 2.8A)
CFE  A 513 (-2.8A)
 1.21A 6n91A-3lggA:
32.1		 6n91A-3lggA:
12.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6N91_B_DCFB401_0
(ADENOSINE DEAMINASE)		 3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens) 		8 / 12 HIS A  88
ASP A  89
SER A 265
HIS A 330
GLU A 333
HIS A 358
ASP A 415
ASP A 416
 CFE  A 513 ( 3.3A)
CFE  A 513 (-3.0A)
None
ZN  A 512 ( 3.5A)
CFE  A 513 (-3.0A)
CFE  A 513 ( 4.3A)
CFE  A 513 ( 2.8A)
CFE  A 513 (-2.8A)
 1.21A 6n91B-3lggA:
32.2		 6n91B-3lggA:
12.42